Duquesne Family Office’s Oracle ORCL Stock Holding History

Duquesne Family Office’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-271,265	Closed	-$32.3M	–	57
2023 Q2	$32.3M	Buy	+271,265	New	+$28M	1.12%	18

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Duquesne Family Office's ORCL Position: Q3 2023 in Review

Duquesne Family Office sold out of Oracle (ORCL) in Q3 2023, closing a stake of 271,265 shares — an estimated $32.3M sold.

Duquesne Family Office first reported a position in ORCL in Q2 2023 and held it in 1 quarter. The position peaked at $32.3M in Q2 2023. 2,528 funds tracked by Wall St. Rank hold ORCL as of Q3 2023.

Duquesne Family Office reported no remaining Oracle position as of Q3 2023 after selling out during the quarter.
Duquesne Family Office sold 271,265 Oracle shares in Q3 2023, an estimated $32.3M.
Duquesne Family Office first reported a position in Oracle in Q2 2023 and held it in 1 quarter.
Duquesne Family Office's Oracle position peaked at $32.3M in Q2 2023.
2,528 funds tracked by Wall St. Rank held Oracle as of Q3 2023.

Based on Duquesne Family Office's 13F filing for Q3 2023, filed 14 Nov 2023.